Cargando…

Minimally invasive follicular thyroid carcinomas: prognostic factors

Although minimally invasive follicular thyroid carcinoma (MI-FTC) is regarded as an indolent tumour, treatment strategies remain controversial. Our aim was to investigate the outcome for patients with MI-FTC and to identify prognostic parameters to facilitate adequate treatment and follow-up. This r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stenson, Gustav, Nilsson, Inga-Lena, Mu, Ninni, Larsson, Catharina, Lundgren, Catharina Ihre, Juhlin, C. Christofer, Höög, Anders, Zedenius, Jan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4949299/ https://www.ncbi.nlm.nih.gov/pubmed/26858184 http://dx.doi.org/10.1007/s12020-016-0876-y

Ejemplares similares

High Ki-67 index in fine needle aspiration cytology of follicular thyroid tumors is associated with increased risk of carcinoma
por: Mu, Ninni, et al.
Publicado: (2018)

Thyroglobulin expression, Ki-67 index, and lymph node ratio in the prognostic assessment of papillary thyroid cancer
por: Lindfors, Helene, et al.
Publicado: (2023)

Prognostic Utility of the Ki-67 Labeling Index in Follicular Thyroid Tumors: a 20-Year Experience from a Tertiary Thyroid Center
por: Hellgren, L. Samuel, et al.
Publicado: (2022)

The Clinical Significance of Lymph Node Ratio and Ki-67 Expression in Papillary Thyroid Cancer
por: Lindfors, Helene, et al.
Publicado: (2021)

GABPA-dependent down-regulation of DICER1 in follicular thyroid tumours
por: Paulsson, Johan O, et al.
Publicado: (2020)

Development of metastatic poorly differentiated thyroid cancer from a sub-centimeter papillary thyroid carcinoma in a young patient with a germline MET mutation – association or random chance?
por: Johansson, Klara, et al.
Publicado: (2021)

Clinical Routine TERT Promoter Mutational Screening of Follicular Thyroid Tumors of Uncertain Malignant Potential (FT-UMPs): A Useful Predictor of Metastatic Disease
por: Hysek, Martin, et al.
Publicado: (2019)

Metastatic-prone telomerase reverse transcriptase (TERT) promoter and v-Raf murine sarcoma viral oncogene homolog B (BRAF) mutated tall cell variant of papillary thyroid carcinoma arising in ectopic thyroid tissue: A case report
por: Stenman, Adam, et al.
Publicado: (2021)

Primary tumour iodine avidity in relation to uptake in persistent metastatic disease in papillary and poorly differentiated thyroid cancer
por: Nilsson, Joachim N., et al.
Publicado: (2023)

Pre-Therapeutic Measurements of Iodine Avidity in Papillary and Poorly Differentiated Thyroid Cancer Reveal Associations with Thyroglobulin Expression, Histological Variants and Ki-67 Index
por: Nilsson, Joachim N., et al.
Publicado: (2021)

5hmC Immunohistochemistry: A Predictor of TERT Promoter Mutational Status in Follicular Thyroid Carcinoma?
por: Hysek, Martin, et al.
Publicado: (2023)

Nuclear-specific accumulation of telomerase reverse transcriptase (TERT) mRNA in TERT promoter mutated follicular thyroid tumours visualised by in situ hybridisation: a possible clinical screening tool?
por: Hellgren, L Samuel, et al.
Publicado: (2022)

Differential Protein Expression Profiles of Cyst Fluid from Papillary Thyroid Carcinoma and Benign Thyroid Lesions
por: Dinets, Andrii, et al.
Publicado: (2015)

Lipoadenoma of the Parathyroid Gland: Characterization of an Institutional Series Spanning 28 Years
por: Juhlin, C. Christofer, et al.
Publicado: (2020)

Diffuse PTH expression in parathyroid tumors argues against important functional tumor subclones
por: Haglund, Felix, et al.
Publicado: (2016)

Inflammatory infiltrates in parathyroid tumors
por: Haglund, Felix, et al.
Publicado: (2017)

Genetic characterization of large parathyroid adenomas
por: Sulaiman, Luqman, et al.
Publicado: (2012)

Iodine avidity in papillary and poorly differentiated thyroid cancer is predicted by immunohistochemical and molecular work-up
por: Nilsson, Joachim N, et al.
Publicado: (2023)

Signet ring cell variant of follicular thyroid carcinoma: Report of two cases with focus on morphological, expressional and genetic characteristics
por: Hysek, Martin, et al.
Publicado: (2019)

PLEKHS1 Over-Expression is Associated with Metastases and Poor Outcomes in Papillary Thyroid Carcinoma
por: Xing, Xiangling, et al.
Publicado: (2020)

Proteomic profiling of follicular and papillary thyroid tumors
por: Sofiadis, Anastasios, et al.
Publicado: (2012)

Synchronous lateral lymph node metastases from papillary and follicular thyroid carcinoma: case report and review of the literature
por: Stenman, Adam, et al.
Publicado: (2022)

Downregulation and Hypermethylation of GABPB1 Is Associated with Aggressive Thyroid Cancer Features
por: Xing, Xiangling, et al.
Publicado: (2022)

Clinical Routine Application of the Second-generation Neuroendocrine Markers ISL1, INSM1, and Secretagogin in Neuroendocrine Neoplasia: Staining Outcomes and Potential Clues for Determining Tumor Origin
por: Juhlin, Carl Christofer, et al.
Publicado: (2020)

Metastatic Neuroendocrine Neoplasms of Unknown Primary: Clues from Pathology Workup
por: Juhlin, Carl Christofer, et al.
Publicado: (2022)

TERT Promoter Mutated Follicular Thyroid Carcinomas Exhibit a Distinct microRNA Expressional Profile with Potential Implications for Tumor Progression
por: Paulsson, Johan O., et al.
Publicado: (2021)

Solid Cell Nests Within a Parathyroid Gland—Report of an Exceptional Case
por: Juhlin, C. Christofer, et al.
Publicado: (2018)

Prolactin Receptor in Primary Hyperparathyroidism – Expression, Functionality and Clinical Correlations
por: Haglund, Felix, et al.
Publicado: (2012)

Tumour nuclear oestrogen receptor beta 1 correlates inversely with parathyroid tumour weight
por: Haglund, Felix, et al.
Publicado: (2015)

TERT Immunohistochemistry Is a Poor Predictor of TERT Promoter Mutations and Gene Expression in Follicular Thyroid Carcinoma
por: Paulsson, Johan O., et al.
Publicado: (2018)

Macrofollicular Variant of Follicular Thyroid Carcinoma (MV-FTC) with a Somatic DICER1 Gene Mutation: Case Report and Review of the Literature
por: Hellgren, L. Samuel, et al.
Publicado: (2020)

Genetic and epigenetic background and protein expression profiles in relation to telomerase activation in medullary thyroid carcinoma
por: Wang, Na, et al.
Publicado: (2016)

Distinguishing between thyroid and parathyroid nodules by ultrasound: a potential game-changer in clinical practice?
por: Juhlin, C. Christofer, et al.
Publicado: (2023)

Clinical, genetic, and immunohistochemical characterization of 70 Ukrainian adult cases with post-Chornobyl papillary thyroid carcinoma
por: Dinets, Andrii, et al.
Publicado: (2012)

Quality of Life in Patients with Benign Non-toxic Goiter after Surgical Intervention: A Systematic Review and Meta-Analysis
por: Ihre-Lundgren, Catharina
Publicado: (2022)

Telomerase-Dependent and Independent Telomere Maintenance and its Clinical Implications in Medullary Thyroid Carcinoma
por: Wang, Na, et al.
Publicado: (2014)

Frequent Promoter Hypermethylation of the APC and RASSF1A Tumour Suppressors in Parathyroid Tumours
por: Juhlin, C. Christofer, et al.
Publicado: (2010)

Whole-genome Sequencing of Follicular Thyroid Carcinomas Reveal Recurrent Mutations in MicroRNA Processing Subunit DGCR8
por: Paulsson, Johan O, et al.
Publicado: (2021)

Papillary Thyroid Carcinoma with Desmoid-Like Fibromatosis: Double Trouble?
por: Juhlin, C. Christofer, et al.
Publicado: (2022)

Papillary thyroid carcinoma with pleomorphic tumor giant cells in a pregnant woman – a case report
por: Paulsson, Johan O., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_rm57tpqeanajmls5cgqr137c6j